Loading organizations...

§ Private Profile · Lagos, Lagos, Nigeria
Health tech company offering at-home lab testing and sample collection for accessible medical diagnostics across Africa.
Healthtracka, a health tech company providing at-home lab testing and sample collection, is based in Lagos, Nigeria. The organization aims to make medical diagnostics accessible and affordable across Africa by leveraging an asset-light model, partnering with private labs such as vCare Diagnostics, Lancet Laboratories, and AFRIGLOBAL Medicare. Customers can manage various health conditions, including cholesterol, diabetes, thyroid issues, sexual health, and COVID-19, from home, with offerings encompassing STDs, PCOS, and the first at-home HPV self-sampling kit for cervical cancer screening in Africa. Healthtracka raised $1.5 million in seed funding following its participation in the Techstars Toronto accelerator in October 2021. Initially launching with 5 tests, the company has significantly expanded its diagnostic portfolio to serve individual consumers across Nigeria's top seven cities. It was founded in May 2021 by Ifeoluwa Dare-Johnson and Victor Amusan.
Healthtracka has raised $1.6M across 2 funding rounds.
Healthtracka has raised $1.6M in total across 2 funding rounds.
Healthtracka has raised $1.6M across 2 funding rounds. Most recently, it raised $1.5M Seed in June 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 21, 2022 | $1.5M Seed | — | Alunmi Angels Alliance, Flying Doctors, Hustle Fund, Maya Horgan Famodu | Announced |
| Oct 1, 2021 | $120K Seed | — | Techstars | Announced |
Healthtracka has raised $1.6M in total across 2 funding rounds.
Healthtracka's investors include Alunmi Angels Alliance, Flying Doctors, Hustle Fund, Maya Horgan Famodu, Techstars.
Healthtracka is a Nigeria-based digital health platform offering at-home lab testing with sample collection and digital results delivered in 1-3 days, focusing on preventive care to combat non-communicable diseases in Africa.[1][2][4] It serves consumers and healthcare providers by providing accessible tests for men's health, women's health, sexual health, fertility, STDs, PCOS, cervical cancer screening, and full body checks, solving barriers like travel, cost, and time in diagnostics—especially for underserved communities and rare diseases.[1][3][4][5] With $1.67M raised since its 2021 founding, the company has shown strong growth: network of phlebotomists expanded 20x to over 100, nearly 7,000 tests delivered by mid-2022, and 30% month-over-month revenue growth, evolving from B2C to B2B2C infrastructure for employee testing.[3][5]
Healthtracka was founded in February 2021 by Ifeoluwa Dare-Johnson, inspired by her father's death from an undiagnosed non-communicable disease, highlighting how millions in Africa live unaware of pre-existing conditions.[4][5] Ifeoluwa, leveraging her experience in diagnostics, launched the platform in May 2021 after identifying the need for affordable, home-based testing to promote preventative healthcare and extend lives.[1][4] Early traction came quickly: participation in Techstars Toronto accelerator in October 2021 led to $1.5M seed funding five months later, backed by female VCs, enabling expansion from five initial tests to a broader portfolio.[3][4][5]
Healthtracka rides the digital health wave in Africa, decentralizing diagnostics amid rising non-communicable diseases due to late diagnosis, poor infrastructure, and urban-rural divides.[2][4] Timing aligns with post-COVID demand for remote care, smartphone penetration, and investor interest in healthtech—evident in its accelerator success and funding.[5] Market forces like healthcare burdens, economic productivity losses from illness, and women's health tech growth favor it, positioning Healthtracka to influence ecosystems by enabling data-driven decisions, reducing system strain, and fostering preventative culture starting in Nigeria.[1][2][3][4]
Healthtracka is poised to scale its infrastructure play across Africa, expanding B2B partnerships, test offerings, and rare disease diagnostics while deepening tech integrations for seamless provider access.[2][5] Trends like AI-enhanced insights, regulatory support for telehealth, and rising VC in African healthtech will propel growth, potentially evolving it into a continental diagnostics leader that reshapes preventative care.[3][4] This builds on its mission-born momentum, turning personal loss into widespread health empowerment.